Dyspepsia; simultaneous use of hard-to- digest vegetable, fatty and unusual foods; flatulence associated with the above disorders; acceleration of the passage of food in the intestine of a functional nature.
active substance: pancreatin;
1 tablet contains 192 mg of pancreatin with an activity of at least 5000 amylolytic IU, 7000 lipolytic IU, 400 proteolytic IU;
excipients: lactose monohydrate; microcrystalline cellulose, croscarmellose sodium, crospovidone, povidone, colloidal anhydrous silica, magnesium stearate, polyethylene glycol, azorubin (E 122); dry mixture “Acryl-eze white” containing talc, titanium dioxide (E 171), methacrylate copolymer, sodium lauryl sulfate, sodium bicarbonate, silicon dioxide.
Coated tablets are enteric.
A multi-enzyme drug that promotes digestion. The drug contains the main pancreatic digestive enzymes: lipase, α-amylase, proteases (trypsin and chymotrypsin) – which have lipolytic, amylolytic and proteolytic effects, enhance the breakdown of proteins, carbohydrates and fats in the duodenum. their more complete absorption. Improves the functional state of the digestive tract and normalizes digestive processes.
The tablets have a protective coating that is insoluble in the acidic content of the stomach, which prevents the destruction of pancreatic enzymes under the action of gastric juice. Pancreatic enzymes are active only in the alkaline environment and are released from the dosage form in the alkaline environment of the small intestine, acting in the intestinal lumen.
- Replacement therapy for exocrine insufficiency of the pancreas: chronic pancreatitis, conditions after pancreatectomy, pancreatic cancer, dyspepsia.
- Flatulence, diarrhea of non-infectious origin.
- Impaired digestion (condition after resection of the stomach and small intestine).
- In order to improve the digestion of food in persons with normal digestive tract function in disorders of masticatory function, the use of indigestible plant, fatty or unusual foods; consumption of excessive amounts of food.
- Preparation for X-ray examination and ultrasound diagnostic examinations of abdominal organs (intestinal degassing).
Hypersensitivity to porcine pancreatin / other components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis, intestinal obstruction.
The drug is recommended for use in children over 4 years of age.
Use during pregnancy or breastfeeding
The safety of pancreatin during pregnancy has been insufficiently studied.
During pregnancy or breastfeeding, the drug should be taken as prescribed by a physician if the expected benefit to the mother outweighs the potential risk to the fetus / child.
Method of application and dosage
The dose of Pancreatin depends on the deficiency of pancreatic enzymes in the duodenum and is set individually.
If there are no other recommendations, as well as in cases of indigestion of plant foods, fatty or unusual foods, take 1-2 tablets of Pancreatin. In other cases mentioned above, in case of indigestion, the recommended dose is 2-4 tablets. If necessary, the dose can be increased. Increasing the dose to reduce the symptoms of the disease, such as steatorrhea or abdominal pain, should only be performed under the supervision of a physician. The daily dose of lipase should not exceed 15000-20000 IU per 1 kg of body weight.
Take the tablets with a meal, swallow whole and drink plenty of fluids, such as 1 glass of water.
The duration of treatment depends on the course of the disease and is determined by the doctor individually.
Symptoms: hyperuricosuria, hyperuricemia; in children – constipation.
Treatment: drug withdrawal, adequate hydration, symptomatic therapy.
From the digestive system: very rarely – nausea, vomiting, flatulence, diarrhea, discomfort in the epigastric region, changes in the nature of stools.
Possible hypersensitivity reactions (including rash, itching, sneezing, tearing, bronchospasm, urticaria, anaphylactic reactions), perianal irritation.
Store in the original package at a temperature not exceeding 25 ° C. Keep out of reach of children.